Procedure
SCT
SCT is a medical procedure with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
1(33%)
Terminated
1(33%)
Phase Distribution
Ph phase_1
2
67%
Phase Distribution
2
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 1Safety & dosage
2(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Terminated(1)
Other(1)
Detailed Status
Terminated1
Active, not recruiting1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
0.0%
Most Advanced
Phase 1
Trials by Phase
Phase 12 (100.0%)
Trials by Status
terminated133%
active_not_recruiting133%
unknown133%
Recent Activity
1 active trials
Showing 3 of 3
active_not_recruitingphase_1
Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant
NCT01744223
terminatedphase_1
Treosulfan-TMI Conditioning and Rapamycin GvHD Prophylaxis Before Allo-HSCT
NCT03963024
unknown
Study of the Clinical Efficacy of Autologous SCT in Patients With Critical Limb Ischemia
NCT01311011
Clinical Trials (3)
Showing 3 of 3 trials
NCT01744223Phase 1
Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant
NCT03963024Phase 1
Treosulfan-TMI Conditioning and Rapamycin GvHD Prophylaxis Before Allo-HSCT
NCT01311011
Study of the Clinical Efficacy of Autologous SCT in Patients With Critical Limb Ischemia
All 3 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 3